Tamoxifen and the induction of cancer.

Suppr

超能文献

作者信息

King C M

机构信息

Carcinogenesis Program, Michigan Cancer Foundation, Wayne State University, Detroit 48201, USA.

出版信息

Carcinogenesis. 1995 Jul;16(7):1449-54. doi: 10.1093/carcin/16.7.1449.

DOI:10.1093/carcin/16.7.1449

PMID:7614676

Abstract

摘要

相似文献

Tamoxifen and the induction of cancer.

Carcinogenesis. 1995 Jul;16(7):1449-54. doi: 10.1093/carcin/16.7.1449.

Tamoxifen chemoprevention--are we throwing out the baby with the bathwater?

Cancer Invest. 1994;12(6):671-5. doi: 10.3109/07357909409023053.

Breast cancer: risk, prevention, & tamoxifen.乳腺癌：风险、预防与他莫昔芬。

Am J Nurs. 2001 Apr;101(4):26-35; quiz 36. doi: 10.1097/00000446-200104000-00016.

Tamoxifen to prevent breast cancer.他莫昔芬预防乳腺癌。

Adv Surg. 2000;34:287-99.

Tamoxifen: the herald of a new era of preventive therapeutics.他莫昔芬：预防性治疗新时代的先驱。

J Natl Cancer Inst. 1997 Jun 4;89(11):747-9. doi: 10.1093/jnci/89.11.747.

An overview of considerations for the testing of tamoxifen as a preventive for breast cancer.他莫昔芬作为乳腺癌预防药物的测试相关考量概述。

Ann N Y Acad Sci. 1995 Sep 30;768:141-7. doi: 10.1111/j.1749-6632.1995.tb12117.x.

Tamoxifen and prevention of breast cancer.他莫昔芬与乳腺癌预防

Toxicol Ind Health. 1998 Jul-Aug;14(4):485-99. doi: 10.1177/074823379801400401.

Tamoxifen for the prevention of breast cancer.他莫昔芬用于预防乳腺癌。

Am J Med. 1996 Jun;100(6):665.

Another view of tamoxifen.他莫昔芬的另一种观点。

Am J Nurs. 2001 Apr;101(4):33.

Med Oncol. 2002;19(2):121-3. doi: 10.1385/MO:19:2:121.

引用本文的文献

Array-based detection of persistent organic pollutants via cyclodextrin promoted energy transfer.基于环糊精促进能量转移的持久性有机污染物的阵列检测

Chem Commun (Camb). 2015 Jul 25;51(58):11615-8. doi: 10.1039/c5cc04153h. Epub 2015 Jun 22.

Bioactivation of the cancer chemopreventive agent tamoxifen to quinone methides by cytochrome P4502B6 and identification of the modified residue on the apoprotein.细胞色素 P4502B6 将癌症化学预防剂他莫昔芬生物转化为醌甲基，鉴定其在脱辅基蛋白上的修饰残基。

Drug Metab Dispos. 2012 Dec;40(12):2280-8. doi: 10.1124/dmd.112.047266. Epub 2012 Aug 31.

Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.构建用于评估和临床管理接受抗雌激素和/或芳香化酶抑制剂治疗的乳腺癌患者的数据库。

Clin Cases Miner Bone Metab. 2011 Jan;8(1):37-50.

The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.萘酚选择性雌激素受体调节剂（SERM）LY2066948 被氧化为一种与萘酚马雌激素雌马酚类似的邻醌。

Chem Biol Interact. 2012 Mar 5;196(1-2):1-10. doi: 10.1016/j.cbi.2012.01.004. Epub 2012 Jan 28.

Bioactivation of Selective Estrogen Receptor Modulators (SERMs).选择性雌激素受体调节剂（SERMs）的生物活化

Chem Res Toxicol. 2006 Sep;19(9):1125-37. doi: 10.1021/tx060126v.

Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.化学修饰可调节4'F-DMA（一种新型苯并噻吩选择性雌激素受体调节剂）的雌激素活性、氧化反应性和代谢稳定性。

Chem Res Toxicol. 2006 Jun;19(6):779-87. doi: 10.1021/tx050326r.

Analysis of protein covalent modification by xenobiotics using a covert oxidatively activated tag: raloxifene proof-of-principle study.使用隐蔽氧化活化标签分析外源性物质对蛋白质的共价修饰：雷洛昔芬原理验证研究。

Chem Res Toxicol. 2005 Sep;18(9):1485-96. doi: 10.1021/tx0501738.

A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells.玉米中一种新型内分泌干扰剂，对人乳腺癌和前列腺癌细胞具有促有丝分裂活性。

Environ Health Perspect. 2002 Feb;110(2):169-77. doi: 10.1289/ehp.02110169.

Harvard report on cancer prevention. Causes of human cancer. Prescription drugs.哈佛癌症预防报告。人类癌症病因。处方药。

Cancer Causes Control. 1996 Nov;7 Suppl 1:S45-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验